Aspiring postgraduate students have a renewed chance to apply for CUET PG 2026 as the National Testing Agency extended the ...
The FDA accepted Besremi's application for essential thrombocythemia, supported by SURPASS-ET and EXCEED-ET trial results, with a review target date of August 30, 2026. Essential thrombocythemia is a ...
The Union Public Service Commission (UPSC) will release the Civil Services Examination (CSE) 2026 notification tomorrow, ...
In July 2025, a class 2 resubmission of tab-cel’s BLA was initiated by Atara Biotherapeutics, developer and sponsor of ...